MPS5301 State-of-the-art and emerging technologies
Faculty of Pharmacy and Pharmaceutical Sciences
MPS5301 State-of-the-art and emerging technologies is a level 5, 6-credit-point, postgraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2026 in Semester 1 at Malaysia and Parkville. It has no prerequisites and unlocks 1 unit.
- Credit points
- 6
- Offered in 2026
- Semester 1
- Malaysia, Parkville
- Assessment
- No exam
- 4 tasks
This is the 2026 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review MPS5301.
Requisites
Before MPS5301
Corequisites
Pass these before, or take them in the same semester.
After MPS5301
1 unit list MPS5301 as a prerequisite or corequisite.
Enrolment rules
Prerequisite: one of MPS5201, MPS5202, MPS5203 or MPS5204
Overview
This unit provides you with the opportunity to develop your research and communication skills through analysis of state-of-the-art and emerging technologies and trends that are being implemented across the pharmaceutical development pipeline. As many of these technologies have the capacity to rapidly generate large amounts of data, you will also gain experience in the interpretation and evaluation of statistical methods used in the context of pharmaceutical science. Throughout this unit you will also gain exposure to various concepts that underpin emerging research and development trends in the pharmaceutical industry including formulating and testing a hypothesis, and will develop the skills required to make professionally informed decisions about the design of new scientific investigations, data analysis and the communication of outcomes to a variety of stakeholders.
Offerings in 2026
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Malaysia | On campus |
| First semester | Parkville | On campus |
Assessment
- Workshop AssessmentExercise30%
- Individual Written ReportWritten30%
- Individual Oral PresentationPresentation15%
- Team-based Written ReportWritten25%
Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.
Learning outcomes
When you finish this unit, you should be able to:
- 1
Understand and discuss current and emerging trends in how state-of-the-art technologies are being used to expedite the discovery and development of pharmaceutical agents
- 2
Critically evaluate research literature describing the advantages and limitations with traditional approaches to pharmaceutical development
- 3
Develop a hypothesis-driven approach to define research strategies that would address complex problems using experiments designed according to industry standards
- 4
Interpret and evaluate the outcomes of statistical analysis conducted in the context of pharmaceutical science research
- 5
Demonstrate effective teamwork practices.
Workload and teaching
- Assessments3 hours
- Workshops24 hours
- Applied sessions12 hours
- Teaching approachPeer assisted learning
- Teaching approachCase-based teaching
- Teaching approachActive learning
- Teaching approachEnquiry-based learning
- 24 hours of online modules and preparation for classes
- Twelve 1-hour Q&A applied sessions
- Twelve 2-hour workshops
- 72 hours of independent study
- 12 hours of team-based collaborative work
Learning resources
Technology resources
This unit requires access to a laptop that meets minimum specifications. Free specialist software is available via MoVE.
Contacts
- Chief Examiners
- Dr Manuela Jorg
- Unit Coordinators
- Dr Wei Meng Lim
- Dr Daniel Priebbenow
Common questions
What are the prerequisites for MPS5301?
None, but you must take MPS5302 before or alongside it.
What can I take after MPS5301?
MPS5301 is a prerequisite or corequisite for 1 unit, including MPS5302.
When is MPS5301 offered?
In 2026, MPS5301 runs in Semester 1 at Malaysia and Parkville.
Does MPS5301 have an exam?
No. MPS5301 has 4 assessment tasks and no exam.